Behaving like a multidrug-resistant microbe, C auris is spreading rapidly throughout the world, including in healthcare facilities in the United States.

Dr Anne Peters shares her patients' experiences to describe why hypoglycemia is such an ever-present fear.

With the 'meteoric' rise of medicinal and recreational cannabinoid use, clinicians should be aware of this idiosyncratic gastrointestinal consequence of cannabinoids.

Dr Robert Eckel reviews research from ADA 2017 on alirocumab in patients with diabetes and mixed dyslipidemia.

Physicians with disabilities are one of the most underrepresented groups in medicine. We need to address this, argues Dr Kenny Lin.

Dr Arefa Cassoobhoy highlights one of the week's important news stories for primary care.

Dr Shivani Agarwal reviews new approaches for hypoglycemia in diabetes presented recently at the 2017 American Diabetes Association annual meeting.

Dr David Johnson looks at two new reports that may dismiss this association, thereby relieving our patients' worrying.

Who can safely take hormone therapy and for how long? Are there alternatives? Dr JoAnn Manson answers questions based on the new position statement from the North American Menopause Society.

Dr Arefa Cassoobhoy highlights one of the week's important news stories for primary care.